Sosa HÓ, Matías TB, González MJ, Juárez VR, Estrada HA, Sánchez RMP, Cureño DMA

Language: Spanish
References: 12
Page: 59-64
PDF size: 492.12 Kb.

ABSTRACT

Objective. To describe the prevalence of healthcare-associated infections (HAIS) due to ESKAPE pathogens, at the Hospital Juárez de México from 2013 to 2017.
Material and Methods. An observational, cross-sectional, descriptive and retrospective study was designed; the information was obtained from the Hospital Epidemiological Surveillance Unit of the Hospital Juárez.
Results. We studied 1 312 HAIS due to ESKAPE pathogens, 517 ventilator-associated pneumonia, 199 hospital-acquired pneumonias, 110 cases of surgical site infection, 63 cases of catheter-related bloodstream infection and 22 cases of catheter-associated urinary tract infection.
Conclusions. For hospital epidemiology, it should be a priority to create and strengthen the relationship with the microbiology laboratory to implement a surveillance system for these pathogens; this is a fundamental pillar of epidemiological surveillance.

REFERENCES

1. Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L.B., Scheld, M., Spellberg, B. y Bartlett, J., “Bad bugs, no drugs: no eskape! An update from the Infectious Diseases Society of America”, Clin Infect Dis, 2009; 48 (1): 1-12.

2. Sandora, T.J. y Goldmann, D.A., “Preventing lethal hospital outbreaks of antibiotic-resistant bacteria”, N Engl J Med, 2012, 367 (23): 2168-2170.

3. Bassetti, M., Poulakou, G., Ruppe, E., Bouza, E., Van Hal, S.J. y Brink, A., “Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach”, Intensive Care Med, 2017, 43 (10): 1464-1475.

4. Organización Mundial de la Salud, “Resistencia a los antibióticos”, 2017, disponible en: http://www.who.int/ mediacentre/factsheets/antibiotic-resistance/es/.

5. Llaca-Díaz, J.M., Mendoza-Olazarán, S., Camacho-Ortiz, A., Flores, S. y Garza-González, E., “One-year surveillance of eskape pathogens in an intensive care unit of Monterrey, Mexico”, Chemotherapy, 2012, 58 (6): 475-481.

6. Amábile-Cuevas, C., “Antibiotic resistance in Mexico: a brief overview of the current status and its causes”, J Infect Dev Ctries, 2010, 4 (3): 126-131.

7. Sidler, J.A., Battegay, M., Tschudin-Sutter, S., Widmer, A.F. y Weisser, M., “Enterococci, Clostridium difficile and esbl-producing bacteria: epidemiology, clinical impact and prevention in icy patients”, Swiss Med Wkly, 2014, 144: w14009, doi: 10.4414/smw.2014.14009. eCollection 2014.

8. Weber, D.J., Kanamori, H. y Rutala, W.A., “‘No touch’ technologies for environmental decontamination: focus on ultraviolet devices and hydrogen peroxide systems”, Curr Opin Infect Dis, 2016, 29 (4): 424-431.

9. Hayden, M.K., Blom, D.W., Lyle, E.A., Moore, C.G. y Weinstein, R.A., “Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients’ environment”, Infect Control Hosp Epidemiol, 2008, 29 (2): 149-154.

10. Russotto, V., Cortegiani, A., Fasciana, T., Iozzo, P., Raineri, S.M., Gregoretti, C. et al., “What healthcare workers should know about environmental bacterial contamination in the intensive care unit”, Biomed Res Int, 2017, 2017: 6905450, doi: 10.1155/2017/6905450.

11. Nathan, C. y Cars, O., “Antibiotic resistance: problems, progress, and prospects”, N Engl J Med, 2014, 371 (19): 1761-1763.

12. Morris, A.M., “Antimicrobial stewardship programs: appropriate measures and metrics to study their impact”, Curr Treat Options Infect Dis, 2014, 6 (2): 101-112.